Citation 166362

HALL,IH: LIOU,YF: LEE,KH:. (1982). ANTITUMOR AGENTS. LII. THE EFFECTS OF MOLEPHANTIN ON NUCLEIC ACID AND PROTEIN SYNTHESIS OF EHRLICH ASCITES CELLS.. 71(6)

Citation Details

Title	ANTITUMOR AGENTS. LII. THE EFFECTS OF MOLEPHANTIN ON NUCLEIC ACID AND PROTEIN SYNTHESIS OF EHRLICH ASCITES CELLS.
Authors	HALL,IH: LIOU,YF: LEE,KH:
Year	1982
Volume	71
Issue	6

Summary

Year: 1982

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
2	M-RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	INACTIVE
3	RNA POLYMERASE INHIBITION(RIBOSOMAL)	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
4	RNA(TRANSFER)POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	INACTIVE
5	RIBONUCLEOTIDE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	INACTIVE
6	FORMIC ACID INCORPORATION INTO PURINES INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
7	PHOSPHORIBOSYL PYROPHOSPHATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
8	INOSINIC ACID DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
9	DIHYDROFOLATE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	INACTIVE
10	CARBAMYL PHOSPHATE SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	INACTIVE
11	ASPARTATE TRANSCARBOXAMYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	INACTIVE
12	OROTIDINE-5'-PHOSPHATE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
13	THYMIDYLATE SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	INACTIVE
14	THYMIDINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
15	THYMIDYLATE MONOPHOSPHATE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
16	THYMIDYLATE DIPHOSPHATE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
17	SUCCINATE DEHYDROGENASE INHIBITION(STATE 4)	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
18	SUCCINATE DEHYDROGENASE INHIBITION(STATE 3)	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
19	ALPHA-KETOGLUTARATE DEHYDROGENASE INHIBITION(STATE 4)	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
20	ALPHA-KETOGLUTARATE DEHYDROGENASE INHIBITION(STATE 3)	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLEPHANTIN	ACTIVE
21	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
22	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	INACTIVE
23	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
24	DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
25	M-RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	INACTIVE
26	RNA POLYMERASE INHIBITION(RIBOSOMAL)	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
27	RNA(TRANSFER)POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
28	RIBONUCLEOTIDE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	INACTIVE
29	FORMIC ACID INCORPORATION INTO PURINES INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
30	PHOSPHORIBOSYL PYROPHOSPHATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
31	INOSINIC ACID DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
32	DIHYDROFOLATE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
33	CARBAMYL PHOSPHATE SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	INACTIVE
34	ASPARTATE TRANSCARBOXAMYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
35	OROTIDINE-5'-PHOSPHATE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
36	THYMIDYLATE SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	INACTIVE
37	THYMIDINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
38	THYMIDYLATE MONOPHOSPHATE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
39	THYMIDYLATE DIPHOSPHATE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
40	PHOSPHORYLATION OF HISTONE PROTEIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
41	PHOSPHORYLATION OF NONHISTONE PROTEIN STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE
42	CYCLIC AMP STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MOLEPHANTIN	ACTIVE

Citation 166362

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1